Don Paradiso is gone.
New law firm:
3753 Howard Hughes Pkwy
Suite 200
Las Vegas
Nevada 89169
T: (702) 784-5990
F: (888) 460-8609
E: benbunker@bunkerlawgroup.com
W: www.bunkerlawgroup.com
March 5, 2012
Pink OTC Markets, Inc.
2nd Floor
304 Hudson Street
New York, NY 10013
RE: Playbox (US), Inc.
This firm serves as counsel to Playbox (US), Inc. (hereinafter the “Company”) and
has been retained by the Company for the purposes of: (a) entering into the Attorney
Letter Agreement with Pink OTC Markets, Inc. (hereinafter “Pink OTC”); and (b) posting
this letter on the OTC Disclosure and News Service in accordance with the requirements
set forth in the Attorney Letter Agreement. Pink OTC is entitled to rely upon this letter in
determining whether the Company has made adequate current information publicly
available within the meaning of Rule 144(c)(2) of the Securities Act of 1933.
This law firm serves as regular securities counsel to the Company. The
undersigned attorney is a resident of the United States of America and has been retained
by the Company to render this letter and for other matters as well. The undersigned
attorney is licensed to practice law in the highest court in the state of Nevada and this
letter covers the jurisdiction of the state of Nevada as well as the applicable laws of the
Untied States of America. The undersigned attorney is permitted to practice before the
Securities and Exchange Commission and has not been prohibited from practice
thereunder.
In rendering this letter, we have examined the Quarterly Disclosure Statement for
the period ending December 31, 2011 (hereinafter the “Statement”) posted by the
Company on the OTC Disclosure and News Service on March5, 2012, and such other
Company records, certificates of officers, certificates of public officials, and other
instruments and documents and such questions of law as we have considered necessary
and appropriate as a basis for the opinions expressed herein. All of the sources noted
above are deemed to be reliable.
In rendering this letter, the undersigned attorney has personally met with
management and with all of the Directors of the Company, has reviewed the Statement
published by the Company and personally discussed the Statement with management
and all of the Directors of the Company.
In our opinion, the Quarterly Disclosure Statement constitutes adequate current
information that is publicly available within the meaning of Rule 144(c)(2) under the
Securities Act of 1933 as a result of such Quarterly Disclosure Statement being posted on
the OTC Disclosure and News Service on March 5, 2012, and that the Quarterly
Disclosure Statement includes all of the information that a broker-dealer would be
required to obtain from the Company to publish a quotation for all of the Securities of
Pink OTC Markets, Inc.
March 5, 2012
Page 2 of 2
the Company under Rule 15c2-11 under the Securities and Exchange Act of 1934, and
that the Quarterly Disclosure Statement complies as to form with the Pink Sheets
“Guidelines for Providing Adequate Current Information.”
The unaudited financial statements obtained in the Statement were prepared by
John Meredith with an address of Woodview, 49, Westerham Road, Bassels Green,
Sevenoaks, Kent TN13 2QB, United Kingdom. Mr. Meredith is a CPA with extensive
experience auditing public companies. The transfer agent for the Company is Action
Stock Transfer Corp., 2469 E. Fort Union Blvd, Suite 214, Salt Lake City, UT 84121.
Action Stock Transfer Corp. is registered with the SEC under the Securities Exchange
Act. The undersigned attorney personally confirmed the number of outstanding common
shares of 1,592,936 set forth in the Quarterly Disclosure Statement with Action Stock
Transfer Corp. of even date herewith.
To the best knowledge of this firm, after inquiry of management and the
Directors of the Company, neither the Company nor any 5% holder, or the undersigned
attorney, is currently under investigation by any Federal or state regulatory authority for
any violation of Federal or state securities laws.
Pink OTC Markets is hereby granted full and complete permission and rights to
publish this letter through the OTC Disclosure and News Service for viewing by the
public and regulators. This letter is rendered solely to Pink OTC and may not be relied
upon by any other person or for any other purpose without prior written consent of this
law firm.
Sincerely,
/s/ Benjamin L. Bunker
BENJAMIN L. BUNKER, ESQ.
BLB
